Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-01-06 @ 6:30 PM
Study NCT ID:
NCT03821233
Status:
COMPLETED
Last Update Posted:
2025-01-29
First Post:
2019-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Sponsor:
Zymeworks BC Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER2-expressing Cancers | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | HER2 | View |
| None | Bispecific antibody | View |
| None | Biparatopic antibody | View |
| None | Immunotherapy | View |
| None | Gastric cancers | View |
| None | Esophageal cancers | View |
| None | Gastroesophageal junction (GEJ) cancers | View |
| None | Breast cancer | View |
| None | Ovarian cancer | View |
| None | Non-small cell lung cancer | View |
| None | Colorectal cancer | View |
| None | Cholangiocarcinoma | View |